|
|
 |
 |
|  |  |
 |  |  |  |  |  |  |  |
modification
 |


|
 PR:000018517 |
   inhibin alpha chain, signal peptide removed form
 |
   INHA/SigPep-
 |
  "An inhibin alpha chain that has had the signal peptide removed." [PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |  |  |  |
modification
 |


|
 PR:000021920 |
   inhibin alpha chain isoform 1, signal peptide removed form
 |
   INHA/iso:1/SigPep-
 |
  "An inhibin alpha chain isoform 1 that has had the signal peptide removed." [PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
modification
 |


|
 PR:000001732 |
   inhibin alpha chain isoform 1 cleaved and glycosylated form
 |
   INHA/iso:1/ClvGlyco+
 |
  "An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
 |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
modification
 |


|
 PR:000001733 |
   inhibin alpha chain isoform 1 cleaved and N-glycosylated 2
 |
   INHA/iso:1/ClvNGlyco:2
 |
  "An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been glycosylated at Asn residues within the two consensus glycosylation sites. Glycosylation favors formation of the inhibin A complex. Example: UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240]
 |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |  |  |
organism-modification
 |


|
 PR:000036608 |
   inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)
 |
   hINHA/iso:1/ClvNGlyco:2
 |
  "An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240, PRO:CNA]
 |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
modification
 |


|
 PR:000001736 |
   inhibin alpha chain isoform 1 cleaved and N-glycosylated 1
 |
   INHA/iso:1/ClvNGlyco:1
 |
  "An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been N-glycosylated at an Asn residue within the first (or unique) consensus glycosylation site. Glycosylation favors formation of the inhibin A complex." [PMID:17456790]
 |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
modification
 |


|
 PR:000001735 |
   inhibin alpha chain isoform 1 mature form
 |
   INHA/iso:1/mature
 |
  "An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by subsequent removal of the propeptide." [PMID:8885240]
 |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-modification
 |


|
 PR:000036609 |
   inhibin alpha chain isoform 1 mature form (human)
 |
   hINHA/iso:1/mature
 |
  "An inhibin alpha chain isoform 1 mature form in human. UniProtKB:P05111-1, 233-366." [PMID:17456790, PRO:CNA]
 |
 Yes | 
|
|
|